This bill mandates that various health insurance providers, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, health maintenance organizations, and the State Health Benefits Program, must cover medically necessary expenses for ovarian cancer screening. This coverage specifically targets symptomatic women or those at risk of ovarian cancer and includes essential diagnostic procedures such as annual pelvic examinations, ultrasounds, and blood tests for cancer markers. The bill ensures that these benefits are provided to the same extent as for any other medical condition under the respective contracts or policies.

The legislation aims to address the significant health risk posed by ovarian cancer, which is a leading cause of cancer-related deaths among women in the United States. By requiring insurance coverage for screening, the bill seeks to facilitate early detection and treatment for women who may exhibit symptoms or have a family history of the disease, thereby improving health outcomes and potentially saving lives. The act will take effect 180 days after enactment and will apply to policies or contracts issued or renewed thereafter.